Left ventricular hypertrophy not always reverts with the decrease in blood pressure;La hipertrofia ventricular izquierda no siempre revierte con el descenso de la presión arterial

Insuficiencia Cardiaca

Volumn 5, Issue 1, 2010, Pages 11-16

  Piskorz, Daniel ^a   Tommasi, Alicia ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Arterial hypertension; Regression; Therapeutic goals; Ventricular hypertrophy

Indexed keywords

EID: 79952017137     PISSN: 18501044     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-352.
2. Verdecchia P, Schillaci G, Borgioni C et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998;97:48-54.
3. Mathew J, Sleight P, Lonn E, et al. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001;104:1615-1621.
4. Devereux RB, Palmieri V, Liu JE, et al. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention for Endpoint Reduction study. J Hypertens 2002;20:1445-1450.
5. Piskorz D, Citta L, Citta N y col. El descenso de la presión arterial no se asocia con regresión de la hipertrofia ventricular izquierda en pacientes hipertensos con síndrome metabólico. Rev Fed Arg Cardiol 2008;37:238-244.
6. Piskorz D, Citta L, Citta N y col. Obesidad central y regresión de la hipertrofia ventricular izquierda. Insuf Card 2007;2:159-162.
7. Chobanian AV, Bakris GL, Black HR y col. National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003;289:2560-2572.
8. Piskorz D, Bendersky M, Farías E y cols. Guías FAC IV. Comité de Epidemiología y Prevención de la Federación Argentina de Cardiología. Hipertensión Arterial. Disponible en http://www.fac.org.ar/1/revista/08v37n4/online/online02/piskorz.php
9. Park SH, Shub C, Nobrega TP. Two dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M mode echocardiography. J Am Soc Echocardiogr 1996;9:119-128.
10. Devereux RB, Pini R, Aurigemma GP, Roman MJ. Measurement of left ventricular mass: methodology and expertise. J Hypertens 1997;15:801-809.
11. Marín M, Díaz M, Piskorz D y col. Consenso de Hipertensión Arterial Consejo Argentino de Hipertensión Arterial "Dr. Eduardo Braun Menéndez" Sociedad Argentina de Cardiología. Rev Arg Cardiol 2007;75(Supl. 3):1-43.
12. De Simone G, Devereux RB, Roman MJ, et al. Inadequate, adequate and inappropriate left ventricular hypertrophy in arterial hypertension. Circulation 1997;96(Suppl I):I-89.
13. Piskorz D, Tommasi A. Importancia de la hipertrofia ventricular izquierda inapropiada en la regresión del daño en órgano blanco. Rev Fed Arg Cardiol 2009;38:80-85.
14. Boutouyrie P, Laurent S, Benetos A, et al. Opposing effects of aging on distal and proximal large arteries in hypertensives. J Hypertens 1992;10(Suppl 6):S87-S92.
15. Cardio-Sis Study Group. Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population. J Hum Hypertens 2008;22:243-251.
16. Verdecchia P, Staessen JA, Angeli F et al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet 2009;374:525-533.
17. Verdecchia P, Sleight P, Avanzini F et al. Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients. Ital Heart J 2003;4:479-483.
18. Verdecchia P, Reboldi G, Angeli F et al. Prognostic Value of Serial Electrocardiographic Voltage and Repolarization Changes in Essential Hypertension: The HEART Survey Study. Am J Hypertens 2007;20:997-1004.